SAM
COLL icon

Sawgrass Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Sawgrass Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,090
Closed -$335K – 169
2020
Q3 		$335K Sell
16,090
-5,255
-25% -$94.8K 0.03% 126
2020
Q2 		$374K Buy
21,345
+3,245
+18% +$63.5K 0.03% 117
2020
Q1 		$296K Buy
+18,100
New +$374K 0.03% 119

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Sawgrass Asset Management's COLL Position: Q4 2020 in Review

Sawgrass Asset Management sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 16,090 shares — an estimated $335K sold.

Sawgrass Asset Management first reported a position in COLL in Q1 2020 and held it in 3 quarters. The position peaked at $374K in Q2 2020. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • Sawgrass Asset Management reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Sawgrass Asset Management sold 16,090 Collegium Pharmaceutical shares in Q4 2020, an estimated $335K.
  • Sawgrass Asset Management first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 3 quarters.
  • Sawgrass Asset Management's Collegium Pharmaceutical position peaked at $374K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Sawgrass Asset Management's 13F filing for Q4 2020, filed 22 Jan 2021.